Lehi, Utah -

Waite Vision is honored to announce that Dr. Aaron Waite, a leading expert in refractive and cataract surgery, traveled to Palos Verdes, California, to speak at STAAR Surgical’s 2024 North American Surgeon Summit. The annual event, known for bringing together the top minds in ophthalmology, provided a platform for surgeons across the nation to exchange knowledge and insights about the latest advancements in vision correction. Dr. Waite was invited to share his expertise on a critical topic in the field: EVO ICL sizing and the safest methods for optimizing outcomes with Implantable Collamer Lenses.

The EVO ICL, developed by STAAR Surgical, is a groundbreaking lens implant that offers patients an alternative to LASIK and other refractive procedures. Designed for individuals with nearsightedness, astigmatism, or thin corneas, the EVO ICL provides excellent visual outcomes with the added benefit of being removable, if necessary. Dr. Waite’s presentation focused on solving one of the most complex challenges in the procedure: determining the best size of lens to ensure safety, comfort, and long-term success. His talk, titled "EVO ICL Sizing Conundrum," addressed key factors influencing lens selection, the nuances of patient anatomy, and techniques for managing complicated cases.

Aaron Waite, MD presenting at STAAR meeting

Drawing from his extensive surgical experience, Dr. Waite discussed the safest and most effective ways to approach challenging cases. These cases often require advanced diagnostic tools, meticulous planning, and a deep understanding of the lens's interaction with the eye’s natural structures. By sharing real-world examples from his practice, Dr. Waite was able to provide attendees with actionable insights into navigating tricky scenarios, reducing risks, and achieving optimal results for their patients. His contributions resonated with his peers, as EVO ICL procedures continue to grow in popularity among patients seeking a less invasive solution for their vision correction needs.

STAAR Surgical, the global leader behind the EVO ICL, has revolutionized vision correction technology with its innovative approach to refractive surgery. The EVO ICL’s biocompatible material, minimally invasive placement, and ability to provide sharp, stable vision make it one of the most sought-after solutions for individuals who may not qualify for LASIK. The Surgeon Summit serves as a hub for STAAR’s community of leading ophthalmologists, fostering collaboration and the exchange of best practices to enhance patient outcomes worldwide. Dr. Waite’s participation underscores his standing as a respected voice in the field and his commitment to advancing the science of vision correction.

As the founder and medical director of Waite Vision, Dr. Waite is widely recognized for his expertise in advanced surgical techniques and his patient-centered approach to care. His dedication to innovation and education has positioned him as a trusted authority on EVO ICL and other vision correction procedures. With a career spanning over a decade, Dr. Waite has performed thousands of surgeries, consistently delivering exceptional results for his patients. His practice, located in Lehi, Utah, is renowned for its state-of-the-art technology, personalized treatment plans, and unwavering focus on achieving life-changing outcomes for individuals seeking visual freedom.

Dr. Waite’s participation in the Surgeon Summit not only highlights his expertise but also reflects the collaborative spirit that drives innovation in ophthalmology. The opportunity to present alongside other esteemed surgeons and engage in meaningful discussions about evolving techniques and technologies demonstrates his dedication to improving patient care on a global scale. The Summit’s focus on the EVO ICL aligns perfectly with Dr. Waite’s passion for utilizing advanced solutions to address complex vision challenges and provide his patients with the best possible outcomes.

In addition to sharing his expertise on EVO ICL sizing, Dr. Waite had the chance to network with fellow pioneers in the field, further enriching his practice’s capabilities. The exchange of ideas at events like this ensures that Waite Vision remains at the forefront of innovation, offering patients access to the most advanced treatments available. For patients considering vision correction, Dr. Waite’s involvement in such high-profile events is a testament to his commitment to excellence and his role as a leader in refractive surgery.

Waite Vision invites anyone interested in learning more about EVO ICL and other advanced vision correction procedures to visit the practice’s website at www.waitevision.com or contact the office at (801) 876-6000. Media inquiries regarding Dr. Waite’s presentation at the Surgeon Summit or his expertise in refractive surgery are welcomed, and Dr. Waite is available for interviews to discuss his insights and experiences in more detail.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]